Search form



CL Mobile Menu

Payal Kohli, MD

Payal Kohli, MD

Dr Kohli is a graduate of Harvard Medical School, where she received a magna cum laude distinction. She completed a residency in Internal Medicine at Harvard Medical School/Brigham & Women’s hospital and a fellowship in cardiovascular diseases at the University of California San Francisco. Currently she is in practice with a cardiovascular medicine group in Denver, Colorado.




Posts by Author

A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?

Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?

Rhythm vs rate control and which medication(s) for which patients, when, and why? Test yourself.

Medicine is finally catching up with the smartphone/smartwatch era – and it’s about time!

Does coffee increase AF risk? How about chocolate? Marijuana? Test yourself with our quiz so you can counsel your patients.

Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?

Digoxin is used in nearly 30% of patients with AF but has never been studied for safety/efficacy in this population, until now.

Some call this new study a "game changer" when it comes to AF patient selection for direct-acting oral anticoagulant Rx. What's your take?

Is exercise safe in HF patients who have AF? Results of the HF-ACTION study are summarized in this short slide show.

A study of a global registry finds that prescriptions for direct oral anticoagulants have now surpassed those for VKAs. What do you Rx?


By clicking Accept, you agree to become a member of the UBM Medica Community.